Skip to content

Bioventus BVS Convertible Preferred Stock Authorized Shares

Convertible Preferred Stock Authorized Shares at other companies

Artivion logo
ArtivionAORT
5M0.0%
Envista Holdings Corporation logo
Envista Holdings CorporationNVST
15M0.0%
IAR
Integra LifeSciencesIART
15M0.0%
Avanos Medical logo
Avanos MedicalAVNS
20M0.0%
Collegium Pharmaceutical, Inc. logo
Collegium Pharmaceutical, Inc.COLL
5M
SI-BONE, Inc. logo
SI-BONE, Inc.SIBN
5M0.0%

Other financials

Income statement

See full
Revenue$132.1M+6.6%
Gross profit$90.8M+9.3%
Operating income$8.4M+72.8%
Net income$3.1M+218%
EPS (diluted)$0.04+200%

Balance sheet

See full
Cash & equivalents$35.8M+57.2%
Total debt$288.4M-21.2%
Total equity$188.9M+27.5%
Total assets$650.5M-5.9%

Cash flow

See full
Operating cash flow$8.9M+146%
CapEx$574.0K-30.5%
Free cash flow$8.4M+141%

Valuation

See full
Market cap$659.19M+51.7%
Enterprise value$911.76M+17.2%
P/E23.1×
P/S1.1×+0.4×

Profitability

See full
Gross margin68.7%+1.2pp
Operating margin10%
Net margin4.9%+3.2pp
FCF margin17.5%+13.2pp

Returns & leverage

See full
Return on equity16.9%+10.9pp
Debt / equity1.5×-0.9×
Current ratio1.7×+0.3×

Where this comes from

Reported directly by Bioventus in its filing.

Tagged under the XBRL concept us-gaap:PreferredStockSharesAuthorized.

The official record: Bioventus’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Bioventus's convertible preferred stock authorized shares.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Bioventus's convertible preferred stock authorized shares?
Bioventus (BVS) reported convertible preferred stock authorized shares of 10M in Q1 2026.
How has Bioventus's convertible preferred stock authorized shares changed year-over-year?
Bioventus's convertible preferred stock authorized shares decreased by 0.0% year-over-year, from 10M to 10M.
What is the long-term trend for Bioventus's convertible preferred stock authorized shares?
Over 4 years (2021 to 2025), Bioventus's convertible preferred stock authorized shares has grown at a 0.0% compound annual growth rate (CAGR), from 10M to 10M.
What does convertible preferred stock authorized shares mean?
Maximum number of convertible preferred shares the company is authorized to issue under its corporate charter.